[HTML][HTML] Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): a systematic review
MA Islam, SS Khandker, PJ Kotyla… - Frontiers in …, 2020 - frontiersin.org
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple
organ involvement, including the skin, joints, kidneys, lungs, central nervous system and the …
organ involvement, including the skin, joints, kidneys, lungs, central nervous system and the …
Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1 …
PJ Kotyla, A Owczarek, J Rakoczy, M Lewicki… - The Journal of …, 2012 - jrheum.org
Objective. To study the influence of anti-tumor necrosis factor-α (TNF-α) treatment on
echocardiographic measures and concentrations of endothelin 1 (ET-1), interleukin 6 (IL-6), and …
echocardiographic measures and concentrations of endothelin 1 (ET-1), interleukin 6 (IL-6), and …
[HTML][HTML] Are Janus kinase inhibitors superior over classic biologic agents in RA patients?
PJ Kotyla - BioMed research international, 2018 - hindawi.com
The Janus Kinases (JAKs) are a family of intracellular tyrosine kinases that provide
transmission signals from cytokine, interferons, and many hormones receptors to the nucleus …
transmission signals from cytokine, interferons, and many hormones receptors to the nucleus …
[HTML][HTML] Thromboembolic adverse drug reactions in Janus kinase (JAK) inhibitors: does the inhibitor specificity play a role?
PJ Kotyla, M Engelmann, J Giemza-Stokłosa… - International journal of …, 2021 - mdpi.com
Recent advances in immunology enabled the characterization of several signal transmitting
pathways responsible for proper cytokine and chemokine signaling. Among them, Janus …
pathways responsible for proper cytokine and chemokine signaling. Among them, Janus …
[HTML][HTML] Clinical aspects of janus kinase (JAK) inhibitors in the cardiovascular system in patients with rheumatoid arthritis
PJ Kotyla, MA Islam, M Engelmann - International journal of molecular …, 2020 - mdpi.com
Janus kinase (JAK) inhibitors, a novel class of targeted synthetic disease-modifying
antirheumatic drugs (DMARDs), have shown their safety and efficacy in rheumatoid arthritis (RA) …
antirheumatic drugs (DMARDs), have shown their safety and efficacy in rheumatoid arthritis (RA) …
[HTML][HTML] Bimodal function of anti-TNF treatment: shall we be concerned about anti-TNF treatment in patients with rheumatoid arthritis and heart failure?
PJ Kotyla - International journal of molecular sciences, 2018 - mdpi.com
Treatment with anti-TNF-α (tumor necrosis factor), one of the pivotal cytokines, was
introduced to clinical practice at the end of last century and revolutionized the treatment of …
introduced to clinical practice at the end of last century and revolutionized the treatment of …
[HTML][HTML] Prevalence of antiphospholipid antibodies in Behçet's disease: a systematic review and meta-analysis
…, SS Khandker, T Reshetnyak, PJ Kotyla… - PLoS …, 2020 - journals.plos.org
Behçet’s disease (BD) is a multifactorial systemic inflammatory disease of unknown aetiology
characterised by several clinical manifestations including vascular involvements (i.e., both …
characterised by several clinical manifestations including vascular involvements (i.e., both …
Hyperferritinaemia: an iron sword of autoimmunity
…, MA Islam, PJ Kotyla - Current pharmaceutical …, 2019 - ingentaconnect.com
Background: Ferritin is a molecule that plays many roles being the storage for iron, signalling
molecule, and modulator of the immune response. Methods: Different electronic databases …
molecule, and modulator of the immune response. Methods: Different electronic databases …
[HTML][HTML] Fibroblast growth factor 23 to alpha-klotho index correlates with systemic sclerosis activity: a proposal for novel disease activity marker
PJ Kotyla, A Kruszec-Zytniewska, AJ Owczarek… - Journal of Clinical …, 2018 - mdpi.com
Systemic sclerosis, a connective tissue disease, is characterized by thickening of the skin,
massive fibrosis of internal organs, vasculopathy, and immune system functioning aberration. …
massive fibrosis of internal organs, vasculopathy, and immune system functioning aberration. …
[HTML][HTML] Cytometric characterization of main immunocompetent cells in patients with systemic sclerosis: relationship with disease activity and type of …
…, G Helbig, J Giemza-Stokłosa, PJ Kotyla - Journal of clinical …, 2019 - mdpi.com
Systemic sclerosis (SSc) is a connective tissue disease that is characterized by widespread
skin and internal organ fibrosis vasculopathy and immune response abnormalities, including …
skin and internal organ fibrosis vasculopathy and immune response abnormalities, including …